<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="case-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2025.1602577</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Case Report: Functional MR imaging of alveolar soft part sarcoma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3020054/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Zhaoyang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Jiuming</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gong</surname>
<given-names>Lihua</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/767318/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Meng</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1788355/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>MRI Room of Qingdao Jiaozhou Central Hospital, Qingdao People&#x2019;s Hospital Group (Jiaozhou)</institution>, <addr-line>Jiaozhou, Shandong</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/896906/overview">Abhishek Mahajan</ext-link>, The Clatterbridge Cancer Centre, United Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1473869/overview">Lisha Duan</ext-link>, Third Hospital of Hebei Medical University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1932878/overview">Syed Faheem Askari Rizvi</ext-link>, Lanzhou University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Lihua Gong, <email xlink:href="mailto:lhgong2005@126.com">lhgong2005@126.com</email>; Meng Li, <email xlink:href="mailto:lmcams@163.com">lmcams@163.com</email>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>&#x2020;These authors share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1602577</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>03</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>08</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Li, Yang, Jiang, Gong and Li.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Li, Yang, Jiang, Gong and Li</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>This study presents a rare case of acinar soft tissue sarcoma and provides a detailed analysis of its multi-parameter quantitative functional MRI (fMRI) characteristics. The patient, a 16-year-old male, was diagnosed with acinar soft tissue sarcoma after presenting with a progressively enlarging mass in the right thigh. To determine the extent and nature of the lesion, MRI examinations were performed using conventional plain scans, contrast-enhanced scans, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), and intravoxel incoherent motion (IVIM) for quantitative analysis. Functional MRI imaging not only provides crucial diagnostic and differential diagnostic information for acinar soft tissue sarcoma, but also reveals through DCE-MRI and IVIM imaging indicators that ASPS exhibits high cellular density, increased vascular permeability, and abundant neovascularization. The local microcirculation characteristics offer vital insights into the tumor&#x2019;s biological behavior and prognosis. Furthermore, functional MRI aids in precise diagnosis while providing references for surgical planning, postoperative adjuvant therapy, long-term follow-up evaluation, and recurrence risk prediction.</p>
</abstract>
<kwd-group>
<kwd>alveolar soft part sarcoma (ASPS)</kwd>
<kwd>dynamic contrast-enhanced magnetic resonance imaging</kwd>
<kwd>intravoxel incoherent motion (IVIM)</kwd>
<kwd>imaging</kwd>
<kwd>diagnosis</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="24"/>
<page-count count="6"/>
<word-count count="2426"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Cancer Imaging and Image-directed Interventions</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Alveolar soft part sarcoma (ASPS) is a rare soft tissue sarcoma and a malignant soft tissue tumor with indeterminate differentiation according to the 2020 version of the &#x201c;WHO Classification of Soft Tissue and Bone Tumors&#x201d; (<xref ref-type="bibr" rid="B1">1</xref>). ASPS is likely to occur in young and middle-aged populations, with a higher incidence in females than in males. The early symptoms and signs are not obvious. It often manifests as a painless mass, which is easy to ignore, and the first manifestation can be metastasis in other locations. MRI is the best imaging examination method for the detection and diagnosis of soft tissue tumors and the evaluation of treatment efficacy because it has high tissue resolution. On conventional MRI, ASPS is shown as an significant and persistent enhancement mass with visible tumor margins and/or internal thickening, dilation, tortuous blood vessels (<xref ref-type="bibr" rid="B2">2</xref>&#x2013;<xref ref-type="bibr" rid="B4">4</xref>). With the advancement of imaging technology, MRI has also developed from conventional morphological imaging to quantitative functional imaging. For the first time, this study reported the multiparametric quantitative functional MRI features of the ASPS of the right thigh to increase awareness of the application of new imaging technologies in the ASPS.</p>
</sec>
<sec id="s2">
<title>Case description</title>
<p>A 16-year-old man was recently diagnosed with a tumor in his right thigh approximately 1 and a half years prior, which had increased significantly. To clarify the scope and nature of the lesion, an MRI examination was performed. Conventional plain and enhanced MRI scans revealed a tumor approximately 5.2 cm &#xd7; 3.7 cm &#xd7; 5.3 cm in the vastus medial muscle of the right thigh; the signal was iso- or slightly hyperintensive on T<sub>1</sub>WI; the fat-suppression sequence on T<sub>2</sub>WI (T<sub>2</sub>WI/FS) revealed a heterogeneous high signal, a high signal on DWI, obvious enhancement on the enhanced scan, and multiple tortuous and thickened vascular shadows in and around the lesions (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A&#x2013;D</bold>
</xref>). Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and intravoxel incoherent motion (IVIM) was performed and the sequence and parameters are shown in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. Within the region of interest (ROI), the quantitative parameters derived from DCE-MRI were as follows: volume transfer constant (K<sup>trans</sup>), and extravascular extracellular volume fraction (V<sub>e</sub>), the rate constants (K<sub>ep</sub>) were 0.81 &#xb1; 0.58/min, 0.23 &#xb1; 0.07, and 3.19 &#xb1; 2.04/min, respectively (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1E&#x2013;G</bold>
</xref>). In addition, the true diffusion coefficient (D) determined via IVIM, the pseudodiffusion coefficient (D<sup>*</sup>), and the perfusion fraction (f) were 0.83 &#xb1; 0.17&#xd7;10<sup>-3</sup> mm2/s, 48.1 &#xb1; 62.5 <sup>&#xd7;10-3</sup> mm2/s, and 28%, respectively (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1I&#x2013;K</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>
<bold>(A-D)</bold> a tumor of approximately 5.2cm&#xd7;3.7cm&#xd7;5.3 cm was observed in the vastus medialis muscle group of the right thigh. The signal was slightly high on T<sub>1</sub>WI, heterogeneously high on T<sub>2</sub>WI/FS in the fat-suppressed sequence, high on DWI, and obvious enhancement on the enhanced scan. <bold>(E-G)</bold> shows pseudocolor images of the DCE-MRI quantitative parameters K<sup>trans</sup>, K<sub>ep</sub> and V<sub>e</sub>. The K<sup>trans</sup>, K<sub>ep</sub> and V<sub>e</sub> value of this soft tissue tumor ROI were (0.81 &#xb1; 0.58)/min, (3.19 &#xb1; 2.04)/min and 0.23 &#xb1; 0.07 respectively. <bold>(H)</bold> TIC curve the figure shows that the signal intensity during the baseline phase is low and stable.After the injection of contrast agent (approximately 24 seconds), the signal intensity rapidly increased and reached its peak (approximately 2716) at the 8th phase (approximately 56.9 seconds).It then gradually declined and stabilized, remaining at a relatively high level of approximately 2200 to 2300. <bold>(I-K)</bold> shows pseudocolour maps of the IVIM quantitative parameters D, D<sup>*</sup>, and f. The D, D<sup>*</sup>, and f value of this soft tissue tumor ROI were 0.83 &#xb1; 0.17&#xd7;10 <sup>-3</sup> mm <sup>2</sup>/s, 48.1 &#xb1; 6.25&#xd7; 10 <sup>-3</sup> mm <sup>2</sup>/s, and 28% respectively. <bold>(L)</bold> The pathological biopsy image shows that the tumor cells are arranged in acinar patterns with abundant blood sinuses (&#x2191;). The tumor cells have abundant cytoplasm, eosinophilic or hyaline vacuolar morphology (&#x25b4;), and obvious nuclear atypia with prominent nucleoli (HE &#xd7;200).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1602577-g001.tif">
<alt-text content-type="machine-generated">Medical imaging of a leg showing various scans in panels A to L. A, B, and C display MRI views with different contrast levels highlighting a mass. D shows a diffusion-weighted image. E, F, and G present color-coded maps, possibly perfusion or diffusion-related. H displays a graph with a line plot, likely showing a specific measurement over time. I, G, and K are additional specialized maps with distinct color scales. L is a histological image showing tissue structure stained for microscopic examination. Each panel illustrates different diagnostic aspects of the suspected abnormality.</alt-text>
</graphic>
</fig>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>The parameters of DCE-MRI and IVIM scan.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Parameter</th>
<th valign="middle" align="left">DCE-MRI</th>
<th valign="middle" align="left">IVIM-DWI</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Sequence type</td>
<td valign="middle" align="left">3D T<sub>1</sub>-weighted spoiled GRE (LAVA)</td>
<td valign="middle" align="left">Single-shot EPI</td>
</tr>
<tr>
<td valign="middle" align="left">Plane</td>
<td valign="middle" align="left">Axial</td>
<td valign="middle" align="left">Axial</td>
</tr>
<tr>
<td valign="middle" align="left">TR/TE<sub>1</sub>/TE<sub>2</sub> (ms)</td>
<td valign="middle" align="left">4.1/1.1/2.2</td>
<td valign="middle" align="left">3000/65/&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="left">Flip angle (&#xb0;)</td>
<td valign="middle" align="left">15</td>
<td valign="middle" align="left">90</td>
</tr>
<tr>
<td valign="middle" align="left">Slice thickness/gap (mm)</td>
<td valign="middle" align="left">4.0/0</td>
<td valign="middle" align="left">4.0/1</td>
</tr>
<tr>
<td valign="middle" align="left">FOV (freq/phase) (mm)</td>
<td valign="middle" align="left">300 &#xd7; 240</td>
<td valign="middle" align="left">250 &#xd7; 250</td>
</tr>
<tr>
<td valign="middle" align="left">Matrix</td>
<td valign="middle" align="left">256 &#xd7; 192</td>
<td valign="middle" align="left">128 &#xd7; 128</td>
</tr>
<tr>
<td valign="middle" align="left">NEX</td>
<td valign="middle" align="left">1</td>
<td valign="middle" align="left">1&#x2013;6</td>
</tr>
<tr>
<td valign="middle" align="left">Bandwidth (Hz/pixel)</td>
<td valign="middle" align="left">142.86</td>
<td valign="middle" align="left">250</td>
</tr>
<tr>
<td valign="middle" align="left">Frequency encoding direction</td>
<td valign="middle" align="left">R/L</td>
<td valign="middle" align="left">R/L</td>
</tr>
<tr>
<td valign="middle" align="left">Number of phases</td>
<td valign="middle" align="left">40</td>
<td valign="middle" align="left">&#x2013;</td>
</tr>
<tr>
<td valign="middle" align="left">b-values (s/mm&#xb2;)</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">0, 10, 20, 40, 60, 80, 100, 150, 200, 400, 800, 1000, 1200, 1500</td>
</tr>
<tr>
<td valign="middle" align="left">Acquisition time</td>
<td valign="middle" align="left">5 min 24 s</td>
<td valign="middle" align="left">4 min 43 s</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>DCE, Dynamic contrast-enhanced magnetic resonance imaging; IVIM, intravoxel incoherent motion; GRE, gradient echo; LAVA, Liver Acquisition with Volume Acceleration; EPI, echo-planar imaging; NEX, number of excitations; FOV, field of view; TR, repetition time; TE, echo time; R/L, right/left.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The patient was admitted on March 24, 2025, and underwent comprehensive MRI and CT examinations on March 26. The integrated CT scan encompassing the chest, abdomen, and pelvis revealed no evidence of metastasis. Puncture on March 29, 2024, revealed tumor cells arranged in an acinar pattern with intervals rich in blood sinuses. The tumor cells exhibit copious cytoplasm, which may be eosinophilic, clear, or vacuolated, accompanied by striking nuclear pleomorphism and conspicuous nucleoli (HE &#xd7;200) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1L</bold>
</xref>). Immunohistochemistry revealed: Vimentin (3+), TFE3 (3+), Ki-67 (5%+), S - 100 (-), confirming the pathological diagnosis of ASPS. Following a thorough assessment, the patient received treatment at another hospital, including three courses of preoperative neoadjuvant targeted therapy (Anlotinib, 12mg QD PO) combined with immunotherapy (Sintilimab, 200mg I.V.) between April 8, 2024 and May 18, 2024. MRI re-examination at external hospital demonstrated a substantial reduction in lesion size, heterogeneous internal signal characteristics, and a notable decrease in the number of blood vessels both within the lesion and along its margins. On June 3, 2024, the patient underwent surgical resection, and postoperative pathology confirmed significant treatment-related changes within the ASPS, with no detectable tumor cells remaining. Following surgery, the patient underwent a regimen of 10 maintenance immunotherapy courses at an external hospital, spanning from June 22, 2024, to January 3, 2025. The patient has been followed up to date, maintaining consistently stable vital signs and health status, while exhibiting no evidence of tumor relapse or distant metastasis. (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Timeline with relevant data about the onset, diagnosis, and therapy of the patient with alveolar soft part sarcoma.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1602577-g002.tif">
<alt-text content-type="machine-generated">Timeline detailing a patient's medical journey for a right thigh mass. Key dates include: March 24, 2024, MRI scan; March 26, 2024, biopsy diagnosis of sarcoma; March 29, 2024, preoperative therapy; April 8 to May 18, 2024, additional treatment; June 3, 2024, surgery showing complete response; June 22, 2024, to January 3, 2025, postoperative immunotherapy.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3" sec-type="discussion">
<title>Discussion</title>
<p>ASPS accounts for less than 1% of sarcoma incidence, predominantly occurs in young and middle-aged adults, and is most commonly found in the lower extremities. Clinically, the early symptoms of ASPS are not obvious, usually manifesting as a painless, gradually enlarging soft tissue mass. The onset age, location, and clinical characteristics of this case are consistent with those reported in the literature (<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>). In this case, the MRI routine examination and MRI contrast-enhanced scan findings of homo sapiens are consistent with previous imaging studies, Pathological findings indicate that the tumor cells are arranged in an acinar pattern, with fissure-like or sinusoidal capillary networks lined by a single layer of flattened endothelial cells between the acini, The pathological manifestations are also highly consistent with the imaging findings (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). The above manifestations all indicate that the tumor has an extremely abundant blood supply. ASPS needs to be differentiated from other hypervascular soft tissue tumors such as aggressive fibromatosis, solitary fibrous tumor etc (<xref ref-type="bibr" rid="B10">10</xref>&#x2013;<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>In recent years, multiparametric MRI&#x2014;notably DCE-MRI and IVIM&#x2014;has demonstrated considerable promise for the qualitative and quantitative assessment of soft tissue tumors (<xref ref-type="bibr" rid="B13">13</xref>). DCE-MRI parameters provide insight into the vascular permeability and hemodynamic characteristics of soft tissue tumors (<xref ref-type="bibr" rid="B14">14</xref>), not only distinguishing benign from malignant tumors but even identifying different malignant subtypes. Both K<sup>trans</sup> and K<sub>ep</sub> effectively distinguish between benign and malignant soft tissue tumors, while K<sub>ep</sub> also effectively distinguishes high-proliferation and low-proliferation subtypes within malignant tumors (<xref ref-type="bibr" rid="B15">15</xref>). IVIM-MRI can more precisely characterize the tumor microenvironment status of via quantitative parameters (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). IVIM leverages multi-b-value DWI to examine water molecule movement characteristics in tissues via a biexponential model, empowering multi-parameter quantitative analysis without requiring exogenous contrast agents. The D value captures the unrestricted diffusion motion of water molecules. This measure is inversely proportional to tissue cellular density, establishing it as a highly accurate diagnostic tool for differentiating benign from malignant soft tissue tumors, particularly for non-myxoid varieties (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Meanwhile, D* and f values reflect the diffusion state of water molecules within the microcirculation and the contribution of microperfusion, respectively, illuminating blood flow and capillary richness within the tumor.</p>
<p>This investigation employed functional MRI imaging techniques&#x2014;specifically DCE-MRI and IVIM sequences&#x2014;to conduct a thorough assessment of the tumor microenvironment and vascular functionality. By analyzing the TIC curve, this case reveals the tumor signal intensity rapidly ascends to its peak within a remarkably short time frame, characterized by a pronounced steep ascending slope and a relatively confined area under the peak. This pattern signifies the contrast agent rapidly arrives at the tumor region and accumulates within the tumor tissue. Meanwhile, the curve displays a more gradual descent, suggesting the contrast agent is excreted more slowly or exhibits retention properties. Research reveals that in neoplastic lesions, the elevation of the area under the curve and the rise slope, coupled with a shortened time to peak, correlate with enhanced regional blood perfusion and/or heightened vascular permeability. These changes may reflect intensified tissue cellular function (<xref ref-type="bibr" rid="B20">20</xref>). The TIC curve for this patient exhibits features that align with these observations. Quantitative analysis demonstrated that the elevated K<sup>trans</sup> value indicates significantly heightened vascular permeability and immature vasculature within the tumor region. A substantial standard deviation signifies considerable variability in K<sup>trans</sup> value distribution, suggesting potential permeability heterogeneity within the lesion. A lower V<sub>e</sub> value signifies that tumor cells are more densely packed within the tumor tissue, suggesting that ASPA is a tumor with relatively dense cellularity. In this instance, the patient displayed elevated K<sup>trans</sup> and K<sub>ep</sub> values. The underlying cause likely stems from the tumor&#x2019;s intensified need for oxygen and nutrients, requiring the formation of more immature, highly permeable neovascularization to deliver nourishment. This enables accelerated blood flow into the hemorrhage circulation, ultimately resulting in increased K<sup>trans</sup> values, and rapidly directs blood flow into the blood vessels, ultimately leading to an increase in K<sub>ep</sub>. This suggests that ASPS exhibits greater local microcirculatory vascular permeability, with enlarged gaps between vascular endothelial cells or poorer vascular maturity in the affected area. DCE-MRI pseudocolor images provide an intuitive visualization of the hemodynamic characteristics within ASPS tumors. IVIM imaging of this case indicates that the lower D value in ASPS may be related to the higher cellular density of ASPA, where densely packed cells restrict water molecule diffusion. D* represents the diffusion state of water molecules in the microcirculatory capillary network. A higher D* value indicates increased intratumoral blood flow velocity and abundant blood supply in ASPA. The f-value quantifies the volumetric proportion of microcirculatory water molecule diffusion relative to the total diffusion effect, serving as a key indicator of tissue capillary density (<xref ref-type="bibr" rid="B21">21</xref>). An elevated f-value corresponds to heightened blood perfusion within ASPS tissues, signifying that microcirculation contributes a substantially greater fraction to the observed signal. The decrease in ADC and D values of ASPA may be attributed to the high density of tumor cells, where the extracellular space is smaller than that of normal tissue, resulting in reduced diffusion of free water molecules. Higher D* and f values both reflect the microperfusion status of capillaries in ASPS tissues, indicating increased neovascularization and enhanced blood flow perfusion within the tumor. IVIM pseudo-color images offer a more intuitive visualization of intricate micro-environmental features within ASPS.</p>
<p>By integrating DCE-MRI and IVIM imaging parameters, ASPS exhibits high cellular density, elevated vascular permeability, and abundant neovascularization. The characteristics of local microcirculation provide crucial information for the biological behavior and prognosis of tumors. Functional MRI not only aids in precise diagnosis, but also provides reference for surgical planning, postoperative adjuvant therapy, and long-term follow-up evaluation.</p>
<p>Although surgery is still the cornerstone of radical treatment for soft tissue tumors, in recent years, neoadjuvant therapy has been increasingly used in high-grade and deep soft tissues patients (<xref ref-type="bibr" rid="B22">22</xref>). As it can improve the tumor microenvironment, shrunk the tumor, facilitate surgery, improve the surgical effect. At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, multiple research studies reported new advancements in immunotherapy and targeted therapy for soft tissue sarcoma (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). In this case, the patient received neoadjuvant targeted therapy and immunotherapy, with the preoperative tumor showing significant reduction in size compared to the primary lesion. Postoperative pathology indicated tumor complete remission. Follow-up to date shows good condition with no signs of relapse or distant metastasis.</p>
<p>In summary, as a rare malignant soft tissue tumor, ASPS is characterized by high cellular density, elevated vascular permeability, and abundant microcirculation. Functional MRI imaging can comprehensively reflect the tumor microenvironment and vascular function information, providing new imaging evidence for tumor diagnosis, surgical planning, postoperative adjuvant therapy, and long-term efficacy evaluation. Moreover, the local microcirculation status of the tumor is closely related to the risk of relapse, and accurate assessment of this indicator is of great significance for the comprehensive management of soft tissue sarcoma.</p>
</sec>
</body>
<back>
<sec id="s4" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s5" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Ethics Committee of Qingdao Jiaozhou Central Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants&#x2019; legal guardians/next of kin. Written informed consent was obtained from the individual(s), and minor(s)&#x2019; legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>JL: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. ZY: Data curation, Writing &#x2013; original draft. JJ: Data curation, Software, Writing &#x2013; original draft. LG: Investigation, Project administration, Writing &#x2013; original draft. ML: Investigation, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research and/or publication of this article.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kallen</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Hornick</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>The 2020 WHO Classification: what&#x2019;s new in soft tissue tumor pathology</article-title>? <source>AmJ Surg Pathol</source>. (<year>2021</year>) <volume>45</volume>:<fpage>e1</fpage>&#x2013;<lpage>e23</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/PAS.0000000000001552</pub-id>, PMID: <pub-id pub-id-type="pmid">32796172</pub-id></citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gulati</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mittal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Barwad</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pandey</surname> <given-names>R</given-names>
</name>
<name>
<surname>Rastogi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dhamija</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Imaging and pathological features of alveolar soft part sarcoma: analysis of 16 patients</article-title>. <source>Indian J Radiol Imaging.</source> (<year>2021</year>) <volume>31</volume>:<page-range>573&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/s-0041-1735501</pub-id>, PMID: <pub-id pub-id-type="pmid">34790300</pub-id></citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spinnato</surname> <given-names>P</given-names>
</name>
<name>
<surname>Papalexis</surname> <given-names>N</given-names>
</name>
<name>
<surname>Colangeli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Miceli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cromb&#xe9;</surname> <given-names>A</given-names>
</name>
<name>
<surname>Parmeggiani</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Imaging features of alveolar soft part sarcoma: single institution experience and literature review</article-title>. <source>Clin Pract</source>. (<year>2023</year>) <volume>13</volume>:<fpage>1369</fpage>&#x2013;<lpage>1382</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/clinpract13060123</pub-id>, PMID: <pub-id pub-id-type="pmid">37987424</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Alveolar soft part sarcoma in childhood and adolescence: Report of three cases and review of literature</article-title>. <source>Front Pediatr</source>. (<year>2022</year>) <volume>10</volume>:<elocation-id>937112</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fped.2022.937112</pub-id>, PMID: <pub-id pub-id-type="pmid">36467475</pub-id></citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pennacchioli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Fiore</surname> <given-names>M</given-names>
</name>
<name>
<surname>Collini</surname> <given-names>P</given-names>
</name>
<name>
<surname>Radaelli</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dileo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Stacchiotti</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Alveolar soft part sarcoma: clinical presentation, treatment, and outcome in a series of 33 patients at a single institution</article-title>. <source>Ann Surg Oncol</source>. (<year>2010</year>) <volume>17</volume>(<issue>12</issue>):<page-range>3229&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1245/s10434-010-1186-x</pub-id>, PMID: <pub-id pub-id-type="pmid">20593242</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>HK</given-names>
</name>
<name>
<surname>Weon</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HJ</given-names>
</name>
</person-group>. <article-title>The dynamic contrast enhanced-magnetic resonance imaging and diffusion-weighted imaging features of alveolar soft part sarcoma</article-title>. <source>Quant Imaging Med Surg</source>. (<year>2023</year>) <volume>13</volume>(<issue>10</issue>):<page-range>7269&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/qims-23-743</pub-id>, PMID: <pub-id pub-id-type="pmid">37869277</pub-id></citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mcaddy</surname> <given-names>NC</given-names>
</name>
<name>
<surname>Saffar</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liti&#xe8;re</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jespers</surname> <given-names>P</given-names>
</name>
<name>
<surname>Sch&#xf6;ffski</surname> <given-names>P</given-names>
</name>
<name>
<surname>Messiou</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>iCREATE: imaging features of primary and metastatic alveolar soft part sarcoma from the EORTC CREATE study</article-title>. <source>Cancer Imaging.</source> (<year>2020</year>) <volume>20</volume>:<fpage>79</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40644-020-00352-9</pub-id>, PMID: <pub-id pub-id-type="pmid">33121537</pub-id></citation></ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lieberman</surname> <given-names>PH</given-names>
</name>
<name>
<surname>Brennan</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Kimmel</surname> <given-names>M</given-names>
</name>
<name>
<surname>Erlandson</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Garin-Chesa</surname> <given-names>P</given-names>
</name>
<name>
<surname>Flehinger</surname> <given-names>BY</given-names>
</name>
<etal/>
</person-group>. <article-title>Alveolar soft-part sarcoma. A clinico-pathologic study of half a century</article-title>. <source>Cancer-Am Cancer Soc</source>. (<year>1989</year>) <volume>63</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/1097-0142(19890101)63:1&lt;1:aid-cncr2820630102&gt;3.0.co;2-e</pub-id>, PMID: <pub-id pub-id-type="pmid">2642727</pub-id></citation></ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rafizadeh</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Cheraqpour</surname> <given-names>K</given-names>
</name>
<name>
<surname>Amoli</surname> <given-names>FA</given-names>
</name>
<etal/>
</person-group>. <article-title>Alveolar soft part sarcoma of the superior rectus muscle: Case report and review of literature</article-title>. <source>Am J Ophthalmol Case Rep</source>. (<year>2022</year>) <volume>27</volume>:<elocation-id>101645</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajoc.2022.101645</pub-id>, PMID: <pub-id pub-id-type="pmid">35813583</pub-id></citation></ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geramizadeh</surname> <given-names>B</given-names>
</name>
<name>
<surname>Jalali</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Aggressive fibromatosis, clinicopathologic findings of 25 cases; A single-center experience and review of the literature</article-title>. <source>Iran J Pathol</source>. (<year>2017</year>) <volume>12</volume>:<fpage>20</fpage>&#x2013;<lpage>24</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.30699/ijp.2017.23944</pub-id>, PMID: <pub-id pub-id-type="pmid">29760749</pub-id></citation></ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demicco</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Park</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Araujo</surname> <given-names>DM</given-names>
</name>
<etal/>
</person-group>. <article-title>Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model[J</article-title>. <source>Mod Pathol</source>. (<year>2012</year>) <volume>25</volume>:<fpage>1298 1306</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/modpathol.2012.83</pub-id>, PMID: <pub-id pub-id-type="pmid">22575866</pub-id></citation></ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boothe</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Budd</surname> <given-names>GT</given-names>
</name>
<name>
<surname>Smolkin</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>PC</given-names>
</name>
</person-group>. <article-title>Durable near-complete response to Anti-PD-1 checkpoint immunotherapy in a refractory Malignant solitary fibrous tumor of the pleura</article-title>. <source>Case Rep Oncol</source>. (<year>2017</year>) <volume>10</volume>:<fpage>998</fpage>&#x2013;<lpage>1005</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000484041</pub-id>, PMID: <pub-id pub-id-type="pmid">29279705</pub-id></citation></ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Jee</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>CK</given-names>
</name>
<etal/>
</person-group>. <article-title>Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and Malignant soft tissue tumors</article-title>. <source>Brit J Radiol</source>. (<year>1115</year>) <volume>2020</volume>:<fpage>93</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1259/bjr.20191035</pub-id>, PMID: <pub-id pub-id-type="pmid">32649224</pub-id></citation></ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sujlana</surname> <given-names>P</given-names>
</name>
<name>
<surname>Skrok</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fayad</surname> <given-names>LM</given-names>
</name>
</person-group>. <article-title>Review of dynamic contrast-enhanced MRI: Technical aspects and applications in the musculoskeletal system</article-title>. <source>J Magn Reson Imaging.</source> (<year>2018</year>) <volume>47</volume>:<fpage>875</fpage>&#x2013;<lpage>890</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jmri.25810</pub-id>, PMID: <pub-id pub-id-type="pmid">28753225</pub-id></citation></ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Diagnostic performance of dynamic contrast-enhanced MRI and 18F-FDG PET/CT for evaluation of soft tissue tumors and correlation with pathology parameters</article-title>. <source>Acad Radiol</source>. (<year>2022</year>) <volume>29</volume>:<fpage>1842</fpage>&#x2013;<lpage>1851</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.acra.2022.03.009</pub-id>, PMID: <pub-id pub-id-type="pmid">35396157</pub-id></citation></ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>XX</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>YF</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>XG</given-names>
</name>
<etal/>
</person-group>. <article-title>Intravoxel incoherent motion diffusion-weighted imaging and dynamic contrast-enhanced MRI for predicting parametrial invasion in cervical cancer</article-title>. <source>Abdom Radiol</source>. (<year>2024</year>) <volume>49</volume>:<fpage>3232</fpage>&#x2013;<lpage>3240</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00261-024-04339-z</pub-id>, PMID: <pub-id pub-id-type="pmid">38753211</pub-id></citation></ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taher</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Arian</surname> <given-names>A</given-names>
</name>
<name>
<surname>Aghili</surname> <given-names>M</given-names>
</name>
<name>
<surname>Keshvari</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Role of intravoxel incoherent motion and dynamic-contrast-enhanced perfusion in response prediction of patients with colorectal cancer after neoadjuvant chemotherapy</article-title>. <source>Asian Pac J Cancer P.</source> (<year>2023</year>) <volume>25</volume>:<fpage>3029</fpage>&#x2013;<lpage>3037</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.31557/APJCP.2024.25.9.3029</pub-id>, PMID: <pub-id pub-id-type="pmid">39342580</pub-id></citation></ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Diagnostic performance of diffusion MRI for differentiating benign and Malignant nonfatty musculoskeletal soft tissue tumors: A systematic review and meta-analysis</article-title>. <source>J Cancer.</source> (<year>2021</year>) <volume>12</volume>:<fpage>7399</fpage>&#x2013;<lpage>7412</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/jca.62131</pub-id>, PMID: <pub-id pub-id-type="pmid">35003360</pub-id></citation></ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mei</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Intravoxel incoherent motion MRI for the differentiation of benign, intermediate, and Malignant solid soft-tissue tumors</article-title>. <source>J Magn Reson Imaging.</source> (<year>2017</year>) <volume>46</volume>:<fpage>1611</fpage>&#x2013;<lpage>1618</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jmri.25733</pub-id>, PMID: <pub-id pub-id-type="pmid">28419705</pub-id></citation></ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>T&#xfc;rkbey</surname> <given-names>B</given-names>
</name>
<name>
<surname>Thomasson</surname> <given-names>D</given-names>
</name>
<name>
<surname>Pang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bernardo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Choyke</surname> <given-names>PL</given-names>
</name>
</person-group>. <article-title>The role of dynamie contrast-enhanced MRI in cancer diagnosis and treatment</article-title>. <source>Diagn Interv Radiol</source>. (<year>2010</year>) <volume>16</volume>:<page-range>186&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4261/1305-3825.DIR.2537-08.1</pub-id>, PMID: <pub-id pub-id-type="pmid">19885783</pub-id></citation></ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging</article-title>. <source>Eur Radiol</source>. (<year>2016</year>) <volume>26</volume>:<fpage>3888</fpage>&#x2013;<lpage>3898</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00330-016-4241-6</pub-id>, PMID: <pub-id pub-id-type="pmid">26863896</pub-id></citation></ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Tine</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>CT</given-names>
</name>
<name>
<surname>Moreno</surname> <given-names>V</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>de Miguel</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Italiano</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Phase 1b trial Mipasetamab Uzoptirine (ADCT - 601-102) dose escalation in patients with advanced bone and soft tissue sarcomas</article-title>. <source>Am Assoc Cancer Res Annu Meeting 2024 Proc</source>.</citation></ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>WF</given-names>
</name>
</person-group>. <article-title>Progress in the treatment of soft tissue sarcoma in the 2023 annual meeting of the American Society of Clinical Oncology</article-title>. <source>. Zhonghua Zhong Liu Za Zhi</source>. (<year>2023</year>) <volume>46</volume>(<issue>01</issue>):<page-range>48&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3760/cma.j.cn112152-20230803-00057</pub-id>, PMID: <pub-id pub-id-type="pmid">38246780</pub-id></citation></ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spalato-Ceruso</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ghazzi</surname> <given-names>NE</given-names>
</name>
<name>
<surname>Italiano</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>New strategies in soft tissue sarcoma treatment</article-title>. <source>J Hematol Oncol</source>. (<year>2024</year>) <volume>17</volume>:<fpage>76</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13045-024-01580-3</pub-id>, PMID: <pub-id pub-id-type="pmid">39218932</pub-id></citation></ref>
</ref-list>
</back>
</article>